Krystal Biotech, Inc.
KRYSUS売上高
$389M
百万USD
営業利益
$161M
百万USD
純利益
$205M
百万USD
ROE
16.8%
最新FY
EPS
$6.84
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $-16M | - |
| FY2021 | Q2 | - | $-16M | $-0.74 |
| FY2021 | Q3 | - | $-16M | $-0.70 |
| FY2021 | FY | - | $-140M | $-5.49 |
| FY2022 | Q1 | - | $-50M | $-1.99 |
| FY2022 | Q2 | - | $-28M | $-1.10 |
| FY2022 | Q3 | - | $-30M | $-1.17 |
| FY2023 | Q1 | - | $-33M | $-1.25 |
| FY2023 | Q3 | $9M | $81M | $2.79 |
| FY2023 | FY | $51M | $11M | $0.39 |
| FY2024 | Q1 | $45M | $1M | $0.03 |
| FY2024 | Q2 | $70M | $16M | $0.53 |
| FY2024 | Q3 | $84M | $27M | $0.91 |
| FY2024 | FY | $291M | $89M | $3.00 |
| FY2025 | Q1 | $88M | $36M | $1.20 |
| FY2025 | Q2 | $96M | $38M | $1.29 |
| FY2025 | Q3 | $98M | $79M | $2.66 |
| FY2025 | FY | $389M | $205M | $6.84 |
| FY2026 | Q1 | $116M | $56M | $1.83 |
財務データ
| 指標 | FY2017 | FY2019 | FY2020 | FY2021 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | $51M | $291M | $389M |
| 営業利益 | $-5M | $-22M | $-33M | $-145M | $-110M | $66M | $161M |
| 純利益 | $-8M | $-19M | $-32M | $-140M | $11M | $89M | $205M |
| 総資産 | $50M | $209M | $311M | $558M | $818M | $1.1B | $1.3B |
| 純資産 | - | - | - | - | - | - | - |
| 自己資本 | $49M | $203M | $292M | $522M | $779M | $946M | $1.2B |
| 営業CF | - | $-19M | $-26M | $-101M | $-89M | $123M | $201M |
| EPS | - | - | - | $-5.49 | $0.39 | $3.00 | $6.84 |
| BPS | $4.80 | $11.69 | $13.16 | $20.27 | $27.52 | $32.85 | $41.72 |
| ROE | -16.0% | -9.4% | -11.0% | -26.8% | 1.4% | 9.4% | 16.8% |